News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
143,377 Results
Type
Article (4764)
Company Profile (93)
Press Release (138517)
Multimedia
Podcasts (3)
Webinars (6)
Section
Business (44686)
Career Advice (210)
Deals (6827)
Drug Delivery (13)
Drug Development (18408)
Employer Resources (19)
FDA (1715)
Job Trends (2900)
News (70815)
Policy (4087)
Tag
Academia (306)
Accelerated approval (1)
Adcomms (1)
Allergies (20)
Alliances (12725)
ALS (38)
Alzheimer's disease (378)
Antibody-drug conjugate (ADC) (48)
Approvals (1745)
Artificial intelligence (68)
Autoimmune disease (18)
Automation (7)
Bankruptcy (38)
Best Places to Work (2336)
BIOSECURE Act (14)
Biosimilars (17)
Biotechnology (86)
Bladder cancer (30)
Brain cancer (8)
Breast cancer (125)
Cancer (915)
Cardiovascular disease (34)
Career advice (199)
Career pathing (5)
CAR-T (84)
Cell therapy (230)
Cervical cancer (7)
Clinical research (15508)
Collaboration (392)
Compensation (199)
Complete response letters (3)
COVID-19 (465)
CRISPR (20)
C-suite (198)
Cystic fibrosis (37)
Data (1095)
Depression (14)
Diabetes (75)
Diagnostics (825)
Digital health (1)
Diversity, equity & inclusion (8)
Drug discovery (58)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (36)
Earnings (13781)
Editorial (4)
Employer resources (19)
Events (26453)
Executive appointments (347)
FDA (2175)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (6)
Funding (324)
Gene editing (38)
Generative AI (6)
Gene therapy (119)
GLP-1 (142)
Government (377)
Guidances (64)
Healthcare (1794)
HIV (6)
Huntington's disease (9)
IgA nephropathy (18)
Immunology and inflammation (42)
Immuno-oncology (1)
Indications (11)
Infectious disease (498)
Inflammatory bowel disease (62)
Inflation Reduction Act (1)
Influenza (20)
Intellectual property (55)
Interviews (19)
IPO (3144)
IRA (4)
Job creations (698)
Job search strategy (185)
Kidney cancer (3)
Labor market (15)
Layoffs (40)
Legal (768)
Liver cancer (16)
Longevity (2)
Lung cancer (90)
Lymphoma (94)
Machine learning (4)
Management (5)
Manufacturing (162)
MASH (14)
Medical device (574)
Medtech (574)
Mergers & acquisitions (3959)
Metabolic disorders (166)
Multiple sclerosis (36)
NASH (1)
Neurodegenerative disease (27)
Neuropsychiatric disorders (6)
Neuroscience (585)
NextGen: Class of 2025 (892)
Non-profit (277)
Now hiring (7)
Obesity (77)
Opinion (38)
Ovarian cancer (43)
Pain (33)
Pancreatic cancer (45)
Parkinson's disease (64)
Partnered (4)
Patents (100)
Patient recruitment (83)
Peanut (15)
People (17291)
Pharmaceutical (10)
Phase I (6048)
Phase II (7389)
Phase III (3889)
Pipeline (683)
Policy (29)
Postmarket research (249)
Preclinical (2613)
Press Release (51)
Prostate cancer (30)
Psychedelics (3)
Radiopharmaceuticals (50)
Rare diseases (104)
Real estate (1550)
Recruiting (10)
Regulatory (3455)
Reports (15)
Research institute (319)
Resumes & cover letters (20)
Rett syndrome (4)
RNA editing (2)
RSV (6)
Schizophrenia (16)
Series A (60)
Series B (49)
Service/supplier (3)
Sickle cell disease (13)
Special edition (2)
Spinal muscular atrophy (36)
Sponsored (5)
Startups (1049)
State (1)
Stomach cancer (2)
Supply chain (20)
Tariffs (9)
The Weekly (3)
Vaccines (102)
Venture capital (11)
Weight loss (29)
Women's health (4)
Worklife (2)
Date
Today (3)
Last 7 days (144)
Last 30 days (584)
Last 365 days (8788)
2025 (6103)
2024 (9486)
2023 (10278)
2022 (13453)
2021 (13957)
2020 (10817)
2019 (7295)
2018 (5660)
2017 (6599)
2016 (6019)
2015 (7050)
2014 (5393)
2013 (4438)
2012 (4849)
2011 (5270)
2010 (4845)
Location
Africa (142)
Alabama (43)
Alaska (1)
Arizona (30)
Arkansas (2)
Asia (9146)
Australia (2153)
California (2798)
Canada (747)
China (179)
Colorado (44)
Connecticut (98)
Delaware (41)
Europe (23055)
Florida (271)
Georgia (41)
Hawaii (2)
Idaho (11)
Illinois (160)
India (6)
Indiana (138)
Iowa (2)
Japan (77)
Kansas (13)
Kentucky (3)
Louisiana (2)
Maine (2)
Maryland (293)
Massachusetts (2028)
Michigan (90)
Minnesota (125)
Mississippi (1)
Missouri (9)
Montana (8)
Nebraska (2)
Nevada (12)
New Hampshire (5)
New Jersey (561)
New Mexico (6)
New York (649)
North Carolina (368)
North Dakota (5)
Northern California (1275)
Ohio (49)
Oklahoma (5)
Oregon (5)
Pennsylvania (565)
Puerto Rico (5)
Rhode Island (5)
South America (215)
South Carolina (2)
Southern California (1108)
Tennessee (19)
Texas (359)
United States (8930)
Utah (30)
Virginia (20)
Washington D.C. (9)
Washington State (403)
West Virginia (1)
Wisconsin (14)
143,377 Results for "immatics biotechnologies gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immatics Announces Second Quarter 2025 Financial Results and Business Update
August 13, 2025
·
18 min read
Press Releases
Immatics Announces First Quarter 2025 Financial Results and Business Update
May 14, 2025
·
19 min read
Press Releases
Immatics Announces Full Year 2024 Financial Results and Business Update
March 28, 2025
·
24 min read
Press Releases
PEPperPRINT GmbH launches cLIFT technology for next-generation peptide microarrays
June 10, 2025
·
3 min read
Press Releases
Immatics Announces Upcoming Oral and Poster Presentation on IMA203 TCR T-cell Therapy at 2025 ASCO Annual Meeting
April 23, 2025
·
3 min read
Press Releases
Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma
June 2, 2025
·
12 min read
Press Releases
Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
April 22, 2025
·
6 min read
Press Releases
Crescita Therapeutics Announces Mutual Termination of Licensing Agreement with Croma Pharma GmbH for Pliaglis®
May 23, 2025
·
7 min read
Press Releases
Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH
March 19, 2025
·
1 min read
Business
Immatics Announces First Quarter 2024 Financial Results and Business Update
Immatics N.V., a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, provided a business update and reported financial results for the quarter ended March 31, 2024.
May 14, 2024
·
20 min read
1 of 14,338
Next
